Financial Shenanigans

The Forensic Verdict

Risk Score: 42/100 — Elevated, but with unusually candid disclosure. Urban Company's FY2025 headline profit of ₹240 Cr — the centerpiece of its IPO marketing — is almost entirely a one-time non-cash deferred-tax credit of ₹211 Cr, a fact the company itself flagged as a discrete risk in the DRHP. Strip that out and the business pre-tax made ₹29 Cr, of which ₹116 Cr came from interest on the IPO-bound cash pile and the operating segments together booked a ₹40 Cr loss. FY2026, the first full year as a listed entity, reverted to a ₹235 Cr net loss and a ₹99 Cr operating cash outflow. The accounting itself is clean — no restatement, no auditor change, no off-balance-sheet vehicles, no aggressive working-capital lifeline, and management's own non-GAAP framework is more conservative than its statutory earnings. The risk is not that numbers are being manipulated; it is that the headline used to take the company public will not recur, and second-tier metric hygiene (selective Ex-KSA framing, share-based pay excluded from "core profitability") deserves underwriting.

13-Shenanigan Scorecard

Breeding Ground

The governance set-up is materially better than typical for a recently-listed Indian consumer-tech company, which dampens accounting risk even before the numbers are examined. Three co-founder promoters (Bhal, Chandra, Khaitan) hold 19.0% of the equity and run the company day-to-day, but the audit committee is chaired by Shyamal Mukherjee (former PricewaterhouseCoopers India chairman, 32 years' experience) and includes Rajesh Gopinathan (former TCS CEO) and Ireena Vittal (independent director at Asian Paints, Maruti Suzuki, Diageo PLC). Executive director fixed pay is capped at ₹2 Cr per annum each; no bonus or profit-sharing plan; no termination benefits. The promoters and KMP take no related-party revenue and the promoter group is a list of family trusts and HUFs with no operating businesses transacting with Urban Company. The Audit Committee was re-constituted on 12 Nov 2024 and the Risk Management Committee on the same date — institutional governance was in place months before the September 2025 IPO.

Cash compensation is small — the three executive directors collectively took home ₹4.48 Cr (~$540K combined) in FY2025 against a board-approved ceiling of ₹6 Cr. Real compensation flows through ESOPs: ₹73 Cr of share-based pay was charged to P&L in FY25 (₹104 Cr in FY26), or roughly 16x cash pay. That is the lever to watch for incentive alignment, not the salary slips.

Earnings Quality

Reported earnings have been positive in exactly one year — FY2025 — and 88% of that profit was a non-cash deferred-tax credit that the company itself flagged as one-off in its DRHP. Operating losses persist across the full seven-year window, and the underlying margin trajectory is genuine but slower than the headline net-profit line suggests.

The pattern is stark. Operating profit (the dark red bars) has been negative in every year, including FY2025 and FY2026. Treasury income from the cash pile (the green bars) has been positive and growing — exceeding ₹100 Cr from FY24 onwards. Net profit (the blue bars) is positive only in FY25, propelled there by a tax line item — not by an operational inflection.

The DRHP language is explicit: "our restated profit for Fiscal 2025 was largely attributable to our deferred tax which may not recur in the future." The deferred-tax-asset balance jumped from zero to ₹211.7 Cr at March 2025 because management concluded it was now "reasonably certain" future taxable profits would utilise the accumulated tax-loss carryforwards. If that future profitability path slips, the asset reverses through the P&L. FY26 already showed that asset has not grown — a current tax charge of ₹60 Cr was booked against a ₹175 Cr pre-tax loss, deepening rather than offsetting the loss.

Contribution margin moving from 16.5% to 19.5% of NTV over three years is real operating progress and is the strongest piece of clean evidence in this section. The India consumer services segment (the core, ex-Native, ex-InstaHelp, ex-International) is genuinely profitable on a segment-results basis. The forensic concern is not that the operating business is hollow — it is improving — but that the reported earnings line did not represent the operating reality in FY25 and has now diverged again in FY26.

Cash Flow Quality

Operating cash flow turned positive in FY2025 (+₹55 Cr) for the first time, then immediately turned negative again in FY2026 (-₹99 Cr). The mechanism behind FY25's CFO is not unsustainable — it is mostly the ₹73 Cr non-cash share-based-pay add-back. There is no factoring, no supplier finance, no receivable sale, no acquisition-driven distortion, and no aggressive working-capital lifeline. But the underlying business is not yet generating recurring operating cash.

The FY25 "crossover" is more visible on the chart than in the underlying mechanics. In FY25 net profit (red line, +₹240 Cr) lifted above both CFO (blue, +₹55 Cr) and FCF (green, +₹44 Cr) — the opposite of a healthy convergence. The net-profit/CFO gap is the deferred-tax credit: it adds to net profit but is added back (subtracted) in deriving CFO, so it cannot improve cash generation.

Without the share-based-payment add-back of ₹73 Cr — a real cost of compensation funded by share dilution — FY25 CFO would have been roughly -₹18 Cr. The CFO line is mechanically positive because shareholders are paying employees through stock; from a cash-economics perspective the operating business consumed cash even in its "best" year.

Notably, days payable fell from 262 (FY24) to 190 (FY25) — vendors got paid faster, which is a cash headwind. A management trying to flatter CFO would have stretched payables, not shortened them. Inventory days fell from 100 to 87 (lower stock-up, modest cash benefit) and debtor days were stable. None of the working-capital signals suggest the kind of one-time lifeline that often appears around an IPO.

The ₹2,021 Cr cash and investments balance at March 2026 reconciles to the statutory balance sheet (cash + investments ≈ ₹1,262 Cr current investments + ~₹760 Cr cash equivalents grouped under other assets, with ₹472 Cr of net IPO primary capital raised in FY26 ploughed into treasury). Cash is real; the question is whether the operating business will draw on it faster than disclosed (InstaHelp losses of ₹119 Cr per quarter run-rated would consume ₹476 Cr of the war chest in a single year if Q4 FY26 holds).

Metric Hygiene

Management's non-GAAP framing is — surprisingly — more conservative than its statutory earnings, but it leans on selective Ex-KSA framing and excludes a growing, recurring share-based-pay charge. The Adjusted EBITDA reconciliation is fully laid out in the shareholders' letter and aligns line-by-line with the financial statements.

Adjusted EBITDA is not a vehicle for inflating reported numbers here — in FY25 it sits at ₹121M (₹12 Cr), an order of magnitude smaller than net profit of ₹2,398M (₹240 Cr). The non-GAAP number is more conservative because it strips out the very items investors should be skeptical of: treasury yield, deferred-tax credit, and JV-loss accounting. The hygiene risk is in what is also stripped out — share-based pay — and in which growth rate is highlighted.

ESOP charges have grown from ₹57 Cr (FY24) to ₹104 Cr (FY26) and now run at roughly 6-7% of revenue — that is real, recurring economic cost, paid in shares that dilute existing holders. Management excludes it from Adjusted EBITDA. A peer-comparable view should add it back: FY26 Adj EBITDA of -₹129 Cr becomes roughly -₹233 Cr after SBP, and FY25's +₹12 Cr becomes -₹61 Cr.

What to Underwrite Next

The forensic risk is a valuation issue, not a thesis breaker. Reported numbers are auditable, disclosed candidly, and converge with the cash-flow statement. The work is on adjusting the headline — strip the deferred-tax tailwind, treat treasury yield as treasury (not operating), add SBP back to non-GAAP profitability, and use management's own FCF definition that already includes lease costs.

Decision recommendation for the institutional underwriter: treat the accounting risk as a valuation haircut, not a position-sizing limiter or a thesis breaker. Build the base case off Adjusted EBITDA after adding back share-based pay (so call it core EBITDA of roughly -₹61 Cr FY25 and -₹233 Cr FY26) and off operating profit before the one-off deferred-tax credit (₹29 Cr FY25 PBT, -₹175 Cr FY26 PBT). The forensic risk does not invalidate the bull case on the core India services business — contribution margin expansion is real and segment-level Adj EBITDA in the core has compounded — but it does mean the company is not yet what its FY25 headline says it is. The price you pay should reflect FY27, not FY25.